Skip to content

Drug interactions

Enzalutamide + Lomitapide

Severity: Moderate

Enzalutamide and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide may lower lomitapide exposure and reduce LDL-lowering efficacy. Lomitapide is a sensitive CYP3A4 substrate.

What this interaction means in plain words

Enzalutamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Enzalutamide belongs to Endocrine; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Enzalutamide induces CYP3A4, increasing lomitapide clearance.

What to do

Monitor LDL cholesterol after starting or stopping enzalutamide and adjust the lomitapide dose as needed. Consider alternatives if lipid control is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Lomitapide?

MediHelp rates the interaction as moderate. Enzalutamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Enzalutamide may lower lomitapide exposure and reduce LDL-lowering efficacy. Lomitapide is a sensitive CYP3A4 substrate.

How serious is the interaction between Enzalutamide and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LDL cholesterol after starting or stopping enzalutamide and adjust the lomitapide dose as needed. Consider alternatives if lipid control is lost.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in